Drug makers’ first-half promotional expenses declined

Two out of five Korean pharmaceutical firms slashed their promotional expenses by more than 30 percent in the first half of this year due to the government’s policy to abandon “rebates” ― a kind of kickback given by drug companies to pharmacies, clinics and hospitals for buying their products.

According to recent figures by Yakup.com, 24 Korean companies listed on the main bourse spent aroun...